The effect of Bongardia Chrysogonum on prostate tissue in a rat model of STZ-induced diabetes
| Autor: | Nebihat Kaplan Sefil, Ahmet Nacar, Oguzhan Ozcan, Kerem Han Gozukara, Ahmet Dokuyucu, Mehmet Inci, Recep Dokuyucu |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
medicine.medical_specialty
endocrine system diseases Urinary system 030232 urology & nephrology Inflammation 03 medical and health sciences Diabetes mellitus 0302 clinical medicine Prostate Internal medicine medicine Glucose homeostasis Testosterone Multidisciplinary biology business.industry Research medicine.disease Streptozotocin biology.organism_classification Chrysogonum medicine.anatomical_structure Endocrinology Oxidative stress Bongardia chrysogonum 030220 oncology & carcinogenesis medicine.symptom business medicine.drug |
| Zdroj: | SpringerPlus |
| ISSN: | 2193-1801 |
| DOI: | 10.1186/s40064-016-2973-z |
| Popis: | Background Bongardia chrysogonum is widely used in Turkey for treating urinary tract infections and prostate hypertrophy, and it also has potent hypoglycemic effects and aids glucose homeostasis. Because of the inflammatory conditions in diabetes mellitus (DM), the prostate tissue of men with diabetes is particularly susceptible to developing hypoplasia, and DM produces characteristic pathological changes in prostate tissue. Here, we examined the effects of B. chrysogonum on the prostate tissue of rats with streptozotocin (STZ)-induced diabetes. Results The glucose levels were statistically significantly higher in the diabetic rats than in healthy controls (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink